Merck

Portfolio Companies 2026 for Merck: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Merck accounts for 9 tracked companies with verified cap-table data, 9 of which disclose round sizes totalling $1.8B. The median disclosed raise is $30M, and the largest is Imago BioSciences at $1.4B, ahead of iOnctura ($130M) and Solve Therapeutics ($120M).

The names that recur most often on these portfolio cap tables are Merck (9 companies), Pfizer (2 companies), European Innovation Council Fund (1 company), Yosemite (1 company), Abingworth (1 company), Alexandria Venture Investments (1 company). By latest disclosed round, the market skews Series A (4), Series C (2), Series B (2), Growth (1).

Companies tracked: 9
Disclosed funding total: $1.8B across 9 companies
Median disclosed raise: $30M
Largest raise: Imago BioSciences — $1.4B
Stage mix: Series A 4 · Series C 2 · Series B 2 · Growth 1
Most recent dated round: 2024-08-04

Best funded Merck companies

Imago BioSciences — $1.4B (latest: Series C)
iOnctura — $130M (latest: Series B)
Solve Therapeutics — $120M (latest: Series A)
Koneksa Health — $65M (latest: Series C)
Intensity Therapeutics — $30M (latest: Growth)
PAQ Therapeutics — $30M (latest: Series A)
Strata Oncology — $26M (latest: Series B)
Caresync.website — $22M (latest: Series A)
SynSense — $13M (latest: Series A)

Merck Digital Sciences Studio — related firms and companies (56)

Merck Digital Sciences Studio profile · All research reports